首页 > 最新文献

MD-Onco最新文献

英文 中文
Leiomyosarcoma of the inferior vena cava. Clinical observation 下腔静脉平滑肌肉瘤。临床观察
Pub Date : 2022-03-04 DOI: 10.17650/2782-3202-2022-2-1-14-18
M. M. Davydov, E. Glukhov, A. A. Filatov, M. Shogenov
Leiomyosarcoma of the inferior vena cava (IVC) is a rare malignant tumor observed in 2 % of all leiomyosarcomas. Less than 400 cases are described in the literature, in Russian publications not more than 30. Computed tomography is the most accurate diagnostic method for determination of tumor location, presence or absence of thrombosis and its severity, evaluation of resectability. We present a case of a patient with leiomyosarcoma of the IVC with preoperative diagnosis of adrenocortical carcinoma of the right adrenal gland with tumor thrombosis of the IVC and tumor advancement into the right kidney. During intraoperative revision the tumor was evaluated as primary leiomyosarcoma of the IVC with thrombosis of the iliac veins up to the retrohepatic segment of the IVC and advancement into the right adrenal gland and vascular structures of the right kidney and its pole which was confirmed by histological examination. Surgery is the main method of treatment of leiomyosarcoma of the IVC. Long-term results depend on the volume and radicality of operation. Reconstruction of the IVC is not always necessary. Despite high recurrence rate, there is no consensus on adjuvant treatment. The best results are achieved through interdisciplinary approach involving an oncological surgeon, chemotherapist, vascular surgeon, anesthesiologist. Perioperative planning, coordination, and adherence to oncological methods are crucial for recovery.
摘要下腔静脉平滑肌肉瘤是一种罕见的恶性肿瘤,约占所有平滑肌肉瘤的2%。文献中描述的病例不到400例,在俄罗斯出版物中不超过30例。计算机断层扫描是确定肿瘤位置、有无血栓及其严重程度、评估可切除性的最准确的诊断方法。我们报告一例下腔静脉平滑肌肉瘤患者,术前诊断为右肾上腺肾上腺皮质癌伴下腔静脉肿瘤血栓形成及肿瘤进展至右肾。术中翻修时评估肿瘤为原发性下腔静脉平滑肌肉瘤,髂静脉血栓形成至下腔静脉肝后段,并进展至右肾上腺和右肾及其极血管结构,经组织学检查证实。手术是治疗下颌骨平滑肌肉瘤的主要方法。长期效果取决于手术的规模和力度。下腔静脉的重建并不总是必要的。尽管复发率高,但辅助治疗尚无共识。最好的结果是通过跨学科的方法,包括肿瘤外科医生,化疗,血管外科医生,麻醉师。围手术期计划、协调和坚持肿瘤治疗方法对恢复至关重要。
{"title":"Leiomyosarcoma of the inferior vena cava. Clinical observation","authors":"M. M. Davydov, E. Glukhov, A. A. Filatov, M. Shogenov","doi":"10.17650/2782-3202-2022-2-1-14-18","DOIUrl":"https://doi.org/10.17650/2782-3202-2022-2-1-14-18","url":null,"abstract":"Leiomyosarcoma of the inferior vena cava (IVC) is a rare malignant tumor observed in 2 % of all leiomyosarcomas. Less than 400 cases are described in the literature, in Russian publications not more than 30. Computed tomography is the most accurate diagnostic method for determination of tumor location, presence or absence of thrombosis and its severity, evaluation of resectability. We present a case of a patient with leiomyosarcoma of the IVC with preoperative diagnosis of adrenocortical carcinoma of the right adrenal gland with tumor thrombosis of the IVC and tumor advancement into the right kidney. During intraoperative revision the tumor was evaluated as primary leiomyosarcoma of the IVC with thrombosis of the iliac veins up to the retrohepatic segment of the IVC and advancement into the right adrenal gland and vascular structures of the right kidney and its pole which was confirmed by histological examination. Surgery is the main method of treatment of leiomyosarcoma of the IVC. Long-term results depend on the volume and radicality of operation. Reconstruction of the IVC is not always necessary. Despite high recurrence rate, there is no consensus on adjuvant treatment. The best results are achieved through interdisciplinary approach involving an oncological surgeon, chemotherapist, vascular surgeon, anesthesiologist. Perioperative planning, coordination, and adherence to oncological methods are crucial for recovery.","PeriodicalId":318498,"journal":{"name":"MD-Onco","volume":"559 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115076412","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multimodal continuous approach to pain management in oncological patients (clinic’s first experience) 肿瘤患者疼痛管理的多模式连续方法(临床首次经验)
Pub Date : 2022-03-04 DOI: 10.17650/2782-3202-2022-2-1-33-38
V. E. Gruzdev, M. A. Anisimov
In current conditions, increased life expectancy led to increased cancer morbidity. Presence of pain syndrome with significant intensity caused development of numerous guidelines on its treatment. Currently, pain management is based on the stepwise multimodal approach of the World Health Organization. In our opinion, wide application of narcotic analgesics is a disadvantage of this method. This pharmaceutical group has a significant number of adverse effects including addiction, development of hyperalgesia, and potential effect of increased rate of cancer recurrence.The study objective is to optimize the stepwise approach by addition of continuous multimodal analgesia. We aim to develop the principles of complex approach to pain management including new combinations of pharmaceuticals of different modalities and new techniques of continuous safe administration using innovative devices.The article presents a prospective description of a series of clinical cases in which new combinations of pharmaceuticals were administered in the context of complex treatment of pain syndrome of significant intensity. Objective evaluation of pain syndrome was performed using the Numeric Rating Scale.Multimodal intravenous pain management using mobile devices administering a mixture of pharmaceuticals in conjunction with basic peroral therapy and widely accepted discrete stepwise approach of the World Health Organization showed first positive results. In our opinion, further studies will allow to 1) decrease the rate of chronic pain syndrome in oncological patients; 2) treat pain syndrome of almost any intensity with preserved quality of life.The first results are encouraging; they show satisfactory effectiveness of the method and its safety. It is necessary to continue studies to develop and standardize the intravenous mixture composition for pain management in the context of the main clinical syndromes determining pain.
在目前的情况下,预期寿命的延长导致癌症发病率的增加。具有显著强度的疼痛综合征的存在引起了许多治疗指南的发展。目前,疼痛管理是基于世界卫生组织的逐步多模式方法。我们认为,麻醉性镇痛药的广泛应用是这种方法的缺点。该药物组具有显著的不良反应,包括成瘾,痛觉过敏的发展,以及增加癌症复发率的潜在影响。研究目的是通过增加连续多模态镇痛来优化逐步方法。我们的目标是发展疼痛管理的复杂方法的原则,包括不同方式的药物的新组合和使用创新设备的持续安全管理的新技术。文章提出了一系列临床病例的前瞻性描述,其中药物的新组合是在显著强度的疼痛综合征的复杂治疗的背景下进行的。采用数值评定量表对疼痛综合征进行客观评价。使用移动装置管理混合药物并结合基本口服治疗和世界卫生组织广泛接受的离散逐步方法的多模式静脉疼痛管理首次显示出积极的结果。在我们看来,进一步的研究将允许1)降低肿瘤患者慢性疼痛综合征的发生率;2)治疗几乎任何强度的疼痛综合征,并保持生活质量。最初的结果令人鼓舞;结果表明,该方法具有良好的有效性和安全性。在确定疼痛的主要临床症状的背景下,有必要继续研究开发和规范静脉内镇痛混合成分。
{"title":"Multimodal continuous approach to pain management in oncological patients (clinic’s first experience)","authors":"V. E. Gruzdev, M. A. Anisimov","doi":"10.17650/2782-3202-2022-2-1-33-38","DOIUrl":"https://doi.org/10.17650/2782-3202-2022-2-1-33-38","url":null,"abstract":"In current conditions, increased life expectancy led to increased cancer morbidity. Presence of pain syndrome with significant intensity caused development of numerous guidelines on its treatment. Currently, pain management is based on the stepwise multimodal approach of the World Health Organization. In our opinion, wide application of narcotic analgesics is a disadvantage of this method. This pharmaceutical group has a significant number of adverse effects including addiction, development of hyperalgesia, and potential effect of increased rate of cancer recurrence.The study objective is to optimize the stepwise approach by addition of continuous multimodal analgesia. We aim to develop the principles of complex approach to pain management including new combinations of pharmaceuticals of different modalities and new techniques of continuous safe administration using innovative devices.The article presents a prospective description of a series of clinical cases in which new combinations of pharmaceuticals were administered in the context of complex treatment of pain syndrome of significant intensity. Objective evaluation of pain syndrome was performed using the Numeric Rating Scale.Multimodal intravenous pain management using mobile devices administering a mixture of pharmaceuticals in conjunction with basic peroral therapy and widely accepted discrete stepwise approach of the World Health Organization showed first positive results. In our opinion, further studies will allow to 1) decrease the rate of chronic pain syndrome in oncological patients; 2) treat pain syndrome of almost any intensity with preserved quality of life.The first results are encouraging; they show satisfactory effectiveness of the method and its safety. It is necessary to continue studies to develop and standardize the intravenous mixture composition for pain management in the context of the main clinical syndromes determining pain.","PeriodicalId":318498,"journal":{"name":"MD-Onco","volume":"43 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114923781","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Aspects of quality of life in pediatric lymphoma patients 儿童淋巴瘤患者生活质量的各个方面
Pub Date : 2022-03-04 DOI: 10.17650/2782-3202-2022-2-1-65-73
O. Sachuk, T. T. Valiev, N. E. Kravchenko, O. Suetina
Background. Quality of life (QL) is no less important question in modern oncohematology than longstanding survival rate and convalescence. Pediatric patients with lymphomas have high chances for recovery, that’s why it is important to provide a good QL during and after end of anti-cancer treatment. In Russia aspects of QL are not give up in pediatric oncohematology and used questionnaires are translated and poor adopted for our country.The study objective is to evaluate parameters of QL in pediatric patients with lymphomas and their parents during anti-cancer treatment and to assign abilities for improvement of QL.Materials and methods. From January 2018 to January 2020 fifty primary pediatric patients with lymphomas and fifty their parents were enrolled the study. All the patients were treated in the Chemotherapy Hemoblastoses Department No. 1 of Pediatric Oncology and Hematology Research Institute of N.N. Blokhin National Medical Research Center of Oncology of the Ministry of Health of Russia. The analysis of QL parameters was performed by Scale “Life satisfaction” of E. Diener, psycho-emotional tension was assessed by questionnaire “Your filling healthy” (for parents), mental activity, motivation, emotional tonus, psychic tension and comfort were analyzed by L.A. Kurgansky and T.A. Nemchin method.Results. 50 % parents and 60 % of children with lymphomas had medium level of life satisfaction. High life satisfaction level was unusual for respondents of pediatric age (0 %) and parents (8 %). During anti-cancer treatment children had low mental activity (60 %), motivation (44 %) and emotional tonus (60 %). It should be noted that psychic tension level in 60 % of children also was low.Conclusion. Anti-cancer treatment, stay in hospital, changed habitual condition favour to decrease QL of patients and their parents, which resulting in low mental activity, embrace of the world around, emotional tonus, not enough life satisfaction. For QL improvement it is necessary to work with psychologists, teachers, social workers, performing of art therapy. A large amount of work should be done with persons closest to child and parents, with whom they will communicate after end of treatment.
背景。在现代血液学中,生活质量(QL)的重要性不亚于长期生存率和恢复期。小儿淋巴瘤患者有很高的康复机会,这就是为什么在抗癌治疗期间和结束后提供良好的QL很重要。俄罗斯在儿童肿瘤血液学中没有放弃QL的各个方面,使用的调查问卷被翻译并很少被我国采用。本研究的目的是评估儿童淋巴瘤患者及其家长在抗癌治疗期间的QL参数,并确定QL的改进能力。材料和方法。从2018年1月到2020年1月,50名原发性儿科淋巴瘤患者及其50名父母参加了这项研究。所有患者均在俄罗斯卫生部肿瘤医学研究中心N.N. Blokhin国家肿瘤医学研究中心儿童肿瘤第一科和血液学研究所接受化疗。QL参数分析采用E. Diener“生活满意度”量表,心理-情绪紧张量表(家长)评估,心理活动、动机、情绪张力、心理紧张和舒适分析采用L.A. Kurgansky和T.A. Nemchin方法。50%的家长和60%的淋巴瘤患儿的生活满意度为中等水平。儿童年龄的受访者(0%)和父母(8%)的生活满意度不高。在抗癌治疗期间,儿童的精神活动(60%)、动机(44%)和情绪紧张(60%)较低。值得注意的是,60%的儿童心理紧张水平也较低。抗癌治疗、住院治疗、改变生活习惯有利于降低患者及家长的QL,导致心理活动度低,对周围世界的拥抱度低,情绪紧张,生活满意度不足。为了改善QL,有必要与心理学家、教师、社会工作者合作,进行艺术治疗。大量的工作应与儿童和父母最亲近的人一起完成,他们将在治疗结束后与他们沟通。
{"title":"Aspects of quality of life in pediatric lymphoma patients","authors":"O. Sachuk, T. T. Valiev, N. E. Kravchenko, O. Suetina","doi":"10.17650/2782-3202-2022-2-1-65-73","DOIUrl":"https://doi.org/10.17650/2782-3202-2022-2-1-65-73","url":null,"abstract":"Background. Quality of life (QL) is no less important question in modern oncohematology than longstanding survival rate and convalescence. Pediatric patients with lymphomas have high chances for recovery, that’s why it is important to provide a good QL during and after end of anti-cancer treatment. In Russia aspects of QL are not give up in pediatric oncohematology and used questionnaires are translated and poor adopted for our country.The study objective is to evaluate parameters of QL in pediatric patients with lymphomas and their parents during anti-cancer treatment and to assign abilities for improvement of QL.Materials and methods. From January 2018 to January 2020 fifty primary pediatric patients with lymphomas and fifty their parents were enrolled the study. All the patients were treated in the Chemotherapy Hemoblastoses Department No. 1 of Pediatric Oncology and Hematology Research Institute of N.N. Blokhin National Medical Research Center of Oncology of the Ministry of Health of Russia. The analysis of QL parameters was performed by Scale “Life satisfaction” of E. Diener, psycho-emotional tension was assessed by questionnaire “Your filling healthy” (for parents), mental activity, motivation, emotional tonus, psychic tension and comfort were analyzed by L.A. Kurgansky and T.A. Nemchin method.Results. 50 % parents and 60 % of children with lymphomas had medium level of life satisfaction. High life satisfaction level was unusual for respondents of pediatric age (0 %) and parents (8 %). During anti-cancer treatment children had low mental activity (60 %), motivation (44 %) and emotional tonus (60 %). It should be noted that psychic tension level in 60 % of children also was low.Conclusion. Anti-cancer treatment, stay in hospital, changed habitual condition favour to decrease QL of patients and their parents, which resulting in low mental activity, embrace of the world around, emotional tonus, not enough life satisfaction. For QL improvement it is necessary to work with psychologists, teachers, social workers, performing of art therapy. A large amount of work should be done with persons closest to child and parents, with whom they will communicate after end of treatment.","PeriodicalId":318498,"journal":{"name":"MD-Onco","volume":"45 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127623075","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Complication of transesophageal fine-needle aspiration of the mediastinal lymph nodes. Clinical observation 经食管纵隔淋巴结细针穿刺的并发症。临床观察
Pub Date : 2022-03-04 DOI: 10.17650/2782-3202-2022-2-1-74-79
I. N. Iurichev, O. Malikhova, S. Gerasimov, V. Vereshchak
Ultrasound-guided fine-needle aspiration is an invasive intervention which is used for diagnosis of additional formations of the walls of the gastrointestinal tract, as well as focal pathologies beyond it. Many reports indicate high diagnostic effectiveness and safety of this method but with increasing number of aspirations endoscopists start to encounter rare complications of this manipulation. The article presents a description of a rare complication which arose during transesophageal fine-needle aspiration, as well as a correct algorithm of patient management in the post-manipulation period.Determination of the correct strategy of patient management led to favorable outcome of the complication and determination of the final clinical diagnosis.
超声引导下的细针穿刺是一种侵入性干预,用于诊断胃肠道壁的额外形成,以及它之外的局灶性病变。许多报告表明这种方法具有较高的诊断有效性和安全性,但随着越来越多的期望内镜医师开始遇到这种操作的罕见并发症。本文报告一例经食道细针穿刺术中出现的罕见并发症,以及操作后患者处理的正确方法。确定正确的患者管理策略可导致并发症的良好结局和最终临床诊断的确定。
{"title":"Complication of transesophageal fine-needle aspiration of the mediastinal lymph nodes. Clinical observation","authors":"I. N. Iurichev, O. Malikhova, S. Gerasimov, V. Vereshchak","doi":"10.17650/2782-3202-2022-2-1-74-79","DOIUrl":"https://doi.org/10.17650/2782-3202-2022-2-1-74-79","url":null,"abstract":"Ultrasound-guided fine-needle aspiration is an invasive intervention which is used for diagnosis of additional formations of the walls of the gastrointestinal tract, as well as focal pathologies beyond it. Many reports indicate high diagnostic effectiveness and safety of this method but with increasing number of aspirations endoscopists start to encounter rare complications of this manipulation. The article presents a description of a rare complication which arose during transesophageal fine-needle aspiration, as well as a correct algorithm of patient management in the post-manipulation period.Determination of the correct strategy of patient management led to favorable outcome of the complication and determination of the final clinical diagnosis.","PeriodicalId":318498,"journal":{"name":"MD-Onco","volume":"297 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122189700","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The role of monoclonal antibodies in treatment of refractory multiple myeloma 单克隆抗体在治疗难治性多发性骨髓瘤中的作用
Pub Date : 2022-03-04 DOI: 10.17650/2782-3202-2022-2-1-48-57
Yu. E. Ryabukhina, O. L. Timofeeva, A. O. Akhov, F. М. Abbasbeyli, P. A. Zeynalova, O. V. Sinitsyna, A. A. Akhobekov, N. Kupryshina, A. G. Zhukov
Multiple myeloma (MM) is a B-cell malignant tumor; its morphological substrate – plasma cells – produces monoclonal immunoglobulin. Primarily, MM is diagnosed in elderly people and is characterized by a variety of clinical manifestations caused by plasma cells infiltration and organ damage. Despite successes in MM therapy, in the majority of cases recurrences of MM or refractory process are observed. In this case, the choice of antitumor drug is usually made depending on its tolerability, toxicity, and availability. Selection of correct treatment can be complicated by such frequent clinical manifestations of MM as osteolytic vertebral lesions leading to development of pathologic compression fractures which in some cases cause spinal cord compression and full immobility in the patients with MM.A clinical case of a 62-year-old female patient with refractory MM is presented. Pathologic compression fractures of the Th12 and L2 vertebral bodies with massive extraosseous component at the Th12 vertebra level posed a threat of spinal cord compression. At the 1st stage, percutaneous vertebroplasty was performed, then antitumor therapy with daratumumab without increased intercycle intervals which significantly increased patient’s quality of life.
多发性骨髓瘤(MM)是一种b细胞恶性肿瘤;其形态底物浆细胞产生单克隆免疫球蛋白。MM主要诊断于老年人,以浆细胞浸润、器官损害等多种临床表现为特征。尽管MM治疗成功,但在大多数情况下,MM复发或难治性过程被观察到。在这种情况下,抗肿瘤药物的选择通常取决于其耐受性,毒性和可用性。MM的常见临床表现为椎体溶骨性病变导致病理性压缩性骨折,在某些情况下导致MM患者脊髓受压和完全不活动,因此选择正确的治疗方法可能会变得复杂。Th12和L2椎体病理性压缩性骨折在Th12椎体水平具有大量骨外成分,对脊髓压迫构成威胁。在第一阶段,经皮椎体成形术,然后在不增加周期间隔的情况下使用daratumumab抗肿瘤治疗,显著提高了患者的生活质量。
{"title":"The role of monoclonal antibodies in treatment of refractory multiple myeloma","authors":"Yu. E. Ryabukhina, O. L. Timofeeva, A. O. Akhov, F. М. Abbasbeyli, P. A. Zeynalova, O. V. Sinitsyna, A. A. Akhobekov, N. Kupryshina, A. G. Zhukov","doi":"10.17650/2782-3202-2022-2-1-48-57","DOIUrl":"https://doi.org/10.17650/2782-3202-2022-2-1-48-57","url":null,"abstract":"Multiple myeloma (MM) is a B-cell malignant tumor; its morphological substrate – plasma cells – produces monoclonal immunoglobulin. Primarily, MM is diagnosed in elderly people and is characterized by a variety of clinical manifestations caused by plasma cells infiltration and organ damage. Despite successes in MM therapy, in the majority of cases recurrences of MM or refractory process are observed. In this case, the choice of antitumor drug is usually made depending on its tolerability, toxicity, and availability. Selection of correct treatment can be complicated by such frequent clinical manifestations of MM as osteolytic vertebral lesions leading to development of pathologic compression fractures which in some cases cause spinal cord compression and full immobility in the patients with MM.A clinical case of a 62-year-old female patient with refractory MM is presented. Pathologic compression fractures of the Th12 and L2 vertebral bodies with massive extraosseous component at the Th12 vertebra level posed a threat of spinal cord compression. At the 1st stage, percutaneous vertebroplasty was performed, then antitumor therapy with daratumumab without increased intercycle intervals which significantly increased patient’s quality of life.","PeriodicalId":318498,"journal":{"name":"MD-Onco","volume":"12 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132855935","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical example of surgical treatment of arteriovenous malformation in right thoracoscopic lobectomy 右胸腔镜肺叶切除术中动静脉畸形的手术治疗临床观察
Pub Date : 2022-03-04 DOI: 10.17650/2782-3202-2022-2-1-58-64
M. M. Davydov, M. V. Serebryanskaya, M. Shogenov, A. A. Filatov, E. Glukhov, V. E. Gruzdev
Pulmonary arteriovenous malformations are a rare congenital pathology observed in 2–3 individuals per 10,000, and 10 % of cases are diagnosed in children in the first several years of life. Arteriovenous malformations are vascular abnormalities of the cardiovascular system presenting as pathological anastomoses (shunts) between the arterial and venous systems which leads to direct shunting of nonoxygenated blood from the arterial bed into the venous bed bypassing pulmonary capillary network. Frequently, diagnosis of pulmonary arteriovenous malformations is made in rather neglected cases. Pulmonary arteriovenous malformations is hard to diagnose and treat, therefore it requires special attention from surgeons and clinicians which prompted us to describe a clinical case of a young 27-year old male patient with signs of significant chronic hypoxia (saturation (SpO2 ) – 84–86 %, hemoglobin level – 185 g/L, erythrocyte count – 6.13 million/μL, hematocrit – 51.8 %; during examination: acrocyanosis, nail clubbing; complaints of vertigo, decreased tolerance of physical activity, breathlessness during physical activity). Computed tomography in the S8, S9 segments showed arteriovenous malformation, size about 70 × 70 mm. Patient underwent radical treatment in the form of right lower thoracoscopic lobectomy which led to an immediate increase in oxygen saturation (SpO2 ) to 99 %. This clinical example shows that surgical method of treatment is the most radical, and thoracoscopic intervention in a young patient significantly decreases the volume of injury and promotes quick recovery and return to active life.
肺动静脉畸形是一种罕见的先天性病理,每10,000人中有2-3例,10%的病例在生命的头几年被诊断出来。动静脉畸形是心血管系统的血管异常,表现为动脉和静脉系统之间的病理性吻合(分流),导致非含氧血液从动脉床直接分流到静脉床,绕过肺毛细血管网络。通常,肺动静脉畸形的诊断是在相当忽视的情况下作出的。肺动静脉畸形难以诊断和治疗,因此需要外科医生和临床医生的特别关注,这促使我们描述了一个27岁的年轻男性患者的临床病例,其体征为明显的慢性缺氧(饱和度(SpO2) - 84 - 86%,血红蛋白水平- 185 g/L,红细胞计数- 613万/μL,红细胞压积- 51.8%;检查时:肢绀、甲棒;主诉眩晕,体力活动耐受性下降,体力活动时呼吸困难)。S8、S9节段ct显示动静脉畸形,大小约70 × 70 mm。患者接受了右下胸腔镜肺叶切除术的根治性治疗,导致氧饱和度(SpO2)立即增加到99%。这个临床例子表明手术治疗方法是最根本的,胸腔镜介入治疗年轻患者可显著减少损伤体积,促进快速恢复和恢复积极生活。
{"title":"Clinical example of surgical treatment of arteriovenous malformation in right thoracoscopic lobectomy","authors":"M. M. Davydov, M. V. Serebryanskaya, M. Shogenov, A. A. Filatov, E. Glukhov, V. E. Gruzdev","doi":"10.17650/2782-3202-2022-2-1-58-64","DOIUrl":"https://doi.org/10.17650/2782-3202-2022-2-1-58-64","url":null,"abstract":"Pulmonary arteriovenous malformations are a rare congenital pathology observed in 2–3 individuals per 10,000, and 10 % of cases are diagnosed in children in the first several years of life. Arteriovenous malformations are vascular abnormalities of the cardiovascular system presenting as pathological anastomoses (shunts) between the arterial and venous systems which leads to direct shunting of nonoxygenated blood from the arterial bed into the venous bed bypassing pulmonary capillary network. Frequently, diagnosis of pulmonary arteriovenous malformations is made in rather neglected cases. Pulmonary arteriovenous malformations is hard to diagnose and treat, therefore it requires special attention from surgeons and clinicians which prompted us to describe a clinical case of a young 27-year old male patient with signs of significant chronic hypoxia (saturation (SpO2 ) – 84–86 %, hemoglobin level – 185 g/L, erythrocyte count – 6.13 million/μL, hematocrit – 51.8 %; during examination: acrocyanosis, nail clubbing; complaints of vertigo, decreased tolerance of physical activity, breathlessness during physical activity). Computed tomography in the S8, S9 segments showed arteriovenous malformation, size about 70 × 70 mm. Patient underwent radical treatment in the form of right lower thoracoscopic lobectomy which led to an immediate increase in oxygen saturation (SpO2 ) to 99 %. This clinical example shows that surgical method of treatment is the most radical, and thoracoscopic intervention in a young patient significantly decreases the volume of injury and promotes quick recovery and return to active life.","PeriodicalId":318498,"journal":{"name":"MD-Onco","volume":"44 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129185266","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Use of stereotactic radiotherapy in treatment of cerebral gliomas 立体定向放射治疗脑胶质瘤的应用
Pub Date : 2021-12-07 DOI: 10.17650/2782-3202-2021-1-1-79-86
M. N. Demina, E. Safronova
{"title":"Use of stereotactic radiotherapy in treatment of cerebral gliomas","authors":"M. N. Demina, E. Safronova","doi":"10.17650/2782-3202-2021-1-1-79-86","DOIUrl":"https://doi.org/10.17650/2782-3202-2021-1-1-79-86","url":null,"abstract":"","PeriodicalId":318498,"journal":{"name":"MD-Onco","volume":"4 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-12-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121999657","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Problems of metastasis (literature review) 转移问题(文献综述)
Pub Date : 2021-12-07 DOI: 10.17650/2782-3202-2021-1-1-93-99
N. Timofeeva, N. V. Bubnova, G. Struchko, I. S. Stomenskaya, O. Kostrova
Despite significant successes in the development of medical sciences, the study of oncopathology issues still occupies a leading place due to the identification of a large number of advanced cases of the disease. Firstly, this may be due to the rapid growth of a malignant tumor, for example, against the background of immunodeficiency. Secondly, with late treatment of patients, when they already have distant metastases. The success of treatment of any oncological process primarily depends on the timing of the diagnosis: the earlier the tumor is diagnosed, the greater the chance of a positive outcome and an increase in the life expectancy of the cancer patient. The most formidable complication of oncopathology and the main cause of death from it is metastasis, which often reduces to zero all the effects of therapy. Metastasis remains a mystery today. So, despite the large number of various theories, the question of the spread of the tumor throughout the body has not yet been resolved. There is no definite answer to the question: do metastases metastasize? The mechanisms of the influence of hormones on the processes of metastasis have not been fully studied. Difficulties in diagnosis are associated with the lack of clinical manifestations before the appearance of metastases, the inability to track and compare changes in tissues and organs in vivo, the non-specificity of the results of available research methods, and the lack of control of the spread of metastases throughout the body. Experimental studies on laboratory animals can provide answers to these and many other questions. In a review of the literature, a study of the main issues of metastasis is conducted.
尽管医学科学的发展取得了重大成就,但由于发现了大量晚期病例,肿瘤病理学问题的研究仍然占据着主导地位。首先,这可能是由于恶性肿瘤的快速生长,例如在免疫缺陷的背景下。其次,患者治疗较晚,已经出现远处转移。任何肿瘤过程的治疗成功与否,主要取决于诊断的时机:肿瘤诊断越早,取得积极疗效的机会就越大,癌症患者的预期寿命也就越长。肿瘤病理学最可怕的并发症和导致死亡的主要原因是转移,它往往会使治疗的所有效果化为零。转移至今仍是一个谜。因此,尽管有大量不同的理论,但肿瘤扩散到全身的问题仍未得到解决。对于 "转移瘤是否会转移?激素对转移过程的影响机制尚未得到充分研究。诊断方面的困难与转移瘤出现前缺乏临床表现、无法跟踪和比较体内组织和器官的变化、现有研究方法的结果缺乏特异性以及无法控制转移瘤在全身的扩散有关。对实验动物的实验研究可以为这些问题和许多其他问题提供答案。在文献综述中,对转移的主要问题进行了研究。
{"title":"Problems of metastasis (literature review)","authors":"N. Timofeeva, N. V. Bubnova, G. Struchko, I. S. Stomenskaya, O. Kostrova","doi":"10.17650/2782-3202-2021-1-1-93-99","DOIUrl":"https://doi.org/10.17650/2782-3202-2021-1-1-93-99","url":null,"abstract":"Despite significant successes in the development of medical sciences, the study of oncopathology issues still occupies a leading place due to the identification of a large number of advanced cases of the disease. Firstly, this may be due to the rapid growth of a malignant tumor, for example, against the background of immunodeficiency. Secondly, with late treatment of patients, when they already have distant metastases. The success of treatment of any oncological process primarily depends on the timing of the diagnosis: the earlier the tumor is diagnosed, the greater the chance of a positive outcome and an increase in the life expectancy of the cancer patient. The most formidable complication of oncopathology and the main cause of death from it is metastasis, which often reduces to zero all the effects of therapy. Metastasis remains a mystery today. So, despite the large number of various theories, the question of the spread of the tumor throughout the body has not yet been resolved. There is no definite answer to the question: do metastases metastasize? The mechanisms of the influence of hormones on the processes of metastasis have not been fully studied. Difficulties in diagnosis are associated with the lack of clinical manifestations before the appearance of metastases, the inability to track and compare changes in tissues and organs in vivo, the non-specificity of the results of available research methods, and the lack of control of the spread of metastases throughout the body. Experimental studies on laboratory animals can provide answers to these and many other questions. In a review of the literature, a study of the main issues of metastasis is conducted.","PeriodicalId":318498,"journal":{"name":"MD-Onco","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-12-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129324099","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Surgical strategy in BRCA-associated breast cancer. Clinical case brca相关乳腺癌的手术策略。临床病例
Pub Date : 2021-12-07 DOI: 10.17650/2782-3202-2021-1-1-87-92
L. Lyubchenko, E. Zelenova, A. A. Suglobova, K. I. Zhordaniya, M. Davydov
{"title":"Surgical strategy in BRCA-associated breast cancer. Clinical case","authors":"L. Lyubchenko, E. Zelenova, A. A. Suglobova, K. I. Zhordaniya, M. Davydov","doi":"10.17650/2782-3202-2021-1-1-87-92","DOIUrl":"https://doi.org/10.17650/2782-3202-2021-1-1-87-92","url":null,"abstract":"","PeriodicalId":318498,"journal":{"name":"MD-Onco","volume":"165 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-12-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127125367","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Combination approach to diagnosis and treatment of an elderly patient with chronic Ph-negative myeloproliferative neoplasm and concomitant surgical pathology. Clinical observation 老年慢性ph阴性骨髓增生性肿瘤伴手术病理的综合诊治。临床观察
Pub Date : 2021-12-06 DOI: 10.17650/2782-3202-2021-1-1-61-65
Yu. E. Ryabukhina, P. A. Zeynalova, O. I. Timofeeva, F. М. Abbasbeyli, T. V. Ponomarev, N. Kupryshina, A. G. Zhukov
Chronic myeloproliferative neoplasms (CMPN), Ph-negative, are of clonal nature, develop on the level of hematopoietic stem cell and are characterized by proliferation of one or more hematopoietic pathways. Currently, the group of Ph-negative CMPN includes essential thrombocythemia, primary myelofibrosis, polycythemia vera, myeloproliferative neoplasm unclassifiable.Identification of mutations in the Jak2 (V617F), CALR, and MPL genes extended understanding of biological features of Ph-negative CMPN and improved differential diagnosis of myeloid neoplasms. Nonetheless, clinical practice still encounters difficulties in clear separation between such disorders as primary myelofibrosis, early-stage and transformation of essential thrombocythemia into myelofibrosis with high thrombocytosis. Thrombocytosis is one of the main risk factors for thromboembolic complications, especially in elderly people.A clinical case of an elderly patient with fracture of the left femur developed in the context of Ph-negative CMPN (myelofibrosis) with high level of thrombocytosis is presented which in combination with enforced long-term immobilization and presence of additional risk created danger of thrombosis and hemorrhage during surgery and in the postoperative period.
慢性骨髓增生性肿瘤(Chronic myeleloprolifative tumour, CMPN), ph阴性,是一种克隆性肿瘤,在造血干细胞水平上发生,以一种或多种造血途径的增殖为特征。目前,ph阴性CMPN组包括原发性血小板增多症、原发性骨髓纤维化、真性红细胞增多症、无法分类的骨髓增殖性肿瘤。Jak2 (V617F)、CALR和MPL基因突变的鉴定扩展了对ph阴性CMPN生物学特征的理解,并改善了髓系肿瘤的鉴别诊断。然而,临床实践中仍难以明确区分原发性髓纤维化、早期和原发性血小板增多症向高血小板增多性髓纤维化转化等疾病。血小板增多是血栓栓塞并发症的主要危险因素之一,尤其是在老年人中。本文报告了一例老年左股骨骨折患者的临床病例,该患者在ph阴性CMPN(骨髓纤维化)伴高水平血小板增多的情况下发生骨折,再加上强制长期固定和手术期间和术后出现血栓和出血的额外风险。
{"title":"Combination approach to diagnosis and treatment of an elderly patient with chronic Ph-negative myeloproliferative neoplasm and concomitant surgical pathology. Clinical observation","authors":"Yu. E. Ryabukhina, P. A. Zeynalova, O. I. Timofeeva, F. М. Abbasbeyli, T. V. Ponomarev, N. Kupryshina, A. G. Zhukov","doi":"10.17650/2782-3202-2021-1-1-61-65","DOIUrl":"https://doi.org/10.17650/2782-3202-2021-1-1-61-65","url":null,"abstract":"Chronic myeloproliferative neoplasms (CMPN), Ph-negative, are of clonal nature, develop on the level of hematopoietic stem cell and are characterized by proliferation of one or more hematopoietic pathways. Currently, the group of Ph-negative CMPN includes essential thrombocythemia, primary myelofibrosis, polycythemia vera, myeloproliferative neoplasm unclassifiable.Identification of mutations in the Jak2 (V617F), CALR, and MPL genes extended understanding of biological features of Ph-negative CMPN and improved differential diagnosis of myeloid neoplasms. Nonetheless, clinical practice still encounters difficulties in clear separation between such disorders as primary myelofibrosis, early-stage and transformation of essential thrombocythemia into myelofibrosis with high thrombocytosis. Thrombocytosis is one of the main risk factors for thromboembolic complications, especially in elderly people.A clinical case of an elderly patient with fracture of the left femur developed in the context of Ph-negative CMPN (myelofibrosis) with high level of thrombocytosis is presented which in combination with enforced long-term immobilization and presence of additional risk created danger of thrombosis and hemorrhage during surgery and in the postoperative period.","PeriodicalId":318498,"journal":{"name":"MD-Onco","volume":"33 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-12-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"125748719","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
MD-Onco
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1